Jo YI - Search Results

1

Puromycin induces reversible proteinuric injury in transgenic mice expressing cyclooxygenase-2 in podocytes.

Jo YI, Cheng H, Wang S, Moeckel GW, Harris RC. Jo YI, et al. Nephron Exp Nephrol. 2007;107(3):e87-94. doi: 10.1159/000108653. Epub 2007 Sep 21. Nephron Exp Nephrol. 2007. PMID: 17890881

2

Overexpression of cyclooxygenase-2 predisposes to podocyte injury.

Cheng H, Wang S, Jo YI, Hao CM, Zhang M, Fan X, Kennedy C, Breyer MD, Moeckel GW, Harris RC. Cheng H, et al. Among authors: jo yi. J Am Soc Nephrol. 2007 Feb;18(2):551-9. doi: 10.1681/ASN.2006090990. Epub 2007 Jan 3. J Am Soc Nephrol. 2007. PMID: 17202413

3

Comparison of survival outcomes in haemodialysis versus immediate-start peritoneal dialysis: A propensity-matched study.

Lee JY, Cho H, Park JH, Jo YI. Lee JY, et al. Among authors: jo yi. Nephrology (Carlton). 2025 Jan;30(1):e14418. doi: 10.1111/nep.14418. Nephrology (Carlton). 2025. PMID: 39675379

4

Switching from acetate to citrate dialysate in a central concentrate delivery system for high-volume online hemodiafiltration: a retrospective cohort study.

Lee JY, Kim KS, Cho HJ, Joo Y, Lee YJ, Park JH, Jo YI. Lee JY, et al. Among authors: jo yi. Ren Fail. 2024 Dec;46(2):2398709. doi: 10.1080/0886022X.2024.2398709. Epub 2024 Sep 9. Ren Fail. 2024. PMID: 39252176 Free PMC article.

5

Tuning the CO₂ Reduction Selectivity of an Immobilized Molecular Ag Complex beyond CO.

Balamurugan M, Jang JH, Kim JE, Choi WI, Jo YI, Park S, Varathan E, Nam KT. Balamurugan M, et al. Among authors: jo yi. Inorg Chem. 2024 Apr 29;63(17):7992-8000. doi: 10.1021/acs.inorgchem.4c01140. Epub 2024 Apr 16. Inorg Chem. 2024. PMID: 38627375

6

Immediate-start peritoneal dialysis without break-in-period: an 18-year retrospective cohort study on patient survival.

Lee JY, Cho HJ, Joo YS, Na HJ, Park JH, Jo YI. Lee JY, et al. Among authors: jo yi. Kidney Res Clin Pract. 2024 Feb 19. doi: 10.23876/j.krcp.23.103. Online ahead of print. Kidney Res Clin Pract. 2024. PMID: 38389148 Free article.

7

Removal of uremic toxin by dialysis, what is the issue?

Jo YI. Jo YI. Kidney Res Clin Pract. 2023 Nov;42(6):672-675. doi: 10.23876/j.krcp.23.115. Epub 2023 Aug 1. Kidney Res Clin Pract. 2023. PMID: 37559226 Free PMC article. No abstract available.

8

Correction: Kim et al. The Medium Cut-Off Membrane Does Not Lower Protein-Bound Uremic Toxins. Toxins 2022, 14, 779.

Kim YG, Lee SH, Jung SW, Jung GT, Lim HJ, Kim KP, Jo YI, Jin K, Moon JY. Kim YG, et al. Among authors: jo yi. Toxins (Basel). 2023 Jan 11;15(1):64. doi: 10.3390/toxins15010064. Toxins (Basel). 2023. PMID: 36668900 Free PMC article.

9

The Medium Cut-Off Membrane Does Not Lower Protein-Bound Uremic Toxins.

Kim YG, Lee SH, Jung SW, Jung GT, Lim HJ, Kim KP, Jo YI, Jin K, Moon JY. Kim YG, et al. Among authors: jo yi. Toxins (Basel). 2022 Nov 10;14(11):779. doi: 10.3390/toxins14110779. Toxins (Basel). 2022. PMID: 36356029 Free PMC article.

10

Why should we focus on high-volume hemodiafiltration?

Shin SK, Jo YI. Shin SK, et al. Among authors: jo yi. Kidney Res Clin Pract. 2022 Nov;41(6):670-681. doi: 10.23876/j.krcp.21.268. Epub 2022 Feb 22. Kidney Res Clin Pract. 2022. PMID: 35286790 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters